Utilizing TH9 cells as a novel therapeutic strategy for malignancies

    loading  Checking for direct PDF access through Ovid

Abstract

TH9 cells join the ever-growing list of CD4+ T helper subsets and primarily mediate anti-parasite immune responses. We have recently demonstrated that tumor-specific TH9 cells induce a CCL20-CCR6-dependent regulation of DCs while stimulating CD8+ T cell-mediated antitumor immunity. These findings offer a novel immunotherapeutic strategy against cancer.

Related Topics

    loading  Loading Related Articles